← Back to Search

STAC Parent Module for Bullying

N/A
Waitlist Available
Research Sponsored by Boise State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate post-training (30 minutes)
Awards & highlights
No Placebo-Only Group

Summary

This study evaluates the feasibility and short-term outcomes of a parent training designed as a companion module to a bullying bystander intervention (STAC) for middle school students in rural communities. The aim of this project is to provide a brief, low-cost intervention that can be easily disseminated as part of a school-based bullying prevention program to address this important public health problem.

Eligible Conditions
  • Bullying

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate post-training (30 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate post-training (30 minutes) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Attitudes About Bullying
Bullying Self-Efficacy
Comfort Managing Bullying
+5 more
Secondary study objectives
Acceptability of the Parent STAC Training
Features of a Technology-Based Program
Interest in Receiving Bullying Prevention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: STAC Parent ModuleExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STAC Parent Module for Middle School
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Boise State UniversityLead Sponsor
12 Previous Clinical Trials
6,497 Total Patients Enrolled
3 Trials studying Bullying
1,010 Patients Enrolled for Bullying
National Institute of General Medical Sciences (NIGMS)NIH
289 Previous Clinical Trials
248,776 Total Patients Enrolled
~6 spots leftby Nov 2025